Physician

A Peter Salas, MD, FACS, FACM

According to 2025 Medicare claims, A. Salas, MD, FACS, FACM (NPI: 1124189030) practices plastic and reconstructive surgery in the Newark, NJ market, with the plurality of this provider's patient population coming from Essex, NJ. This provider's primary affiliated billing organization is SURG-ELITE PC (NPI: 1780878348) and primary practice location at 07052-1080.

Salas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 132 traditional Medicare patients, billed 926 HCPCS/CPT codes, and received $170,098 in Medicare payments. The top billing code was 15100 (Partial thickness self skin graft to trunk, arms, or legs, 100.0 sq cm or 1% body area for infants and children, or less). Part D data shows 53 prescription claims across 33 beneficiaries totaling $4,603 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). 2015 DME data shows 13 claims. Open Payments data shows 21 records totaling $1,249. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $62,629 to $170,098. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,436 and ending at $4,603. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $1,688 and ending at $3,417.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	114	315	$62,629
2016	117	263	$49,259
2017	137	366	$60,037
2018	187	719	$143,121
2019	152	884	$158,180
2020	116	540	$105,576
2021	133	702	$135,153
2022	129	728	$137,897
2023	139	890	$141,755
2024	132	926	$170,098

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	56	$2,436
2016	27	59	$1,190
2017	38	66	$4,277
2018	45	78	$8,951
2019	47	116	$16,440
2020	25	60	$14,300
2021	32	56	$5,945
2022	28	50	$3,506
2023	26	50	$10,929
2024	33	53	$4,603

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$1,756
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
15100	Partial thickness self skin graft to trunk, arms, or legs, 100.0 sq cm or 1% body area for infants and children, or less	13	15	$456
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	36	36	$95
15273	Skin substitute graft to wound 100.0 sq cm or more of trunk, arms, or legs, 100.0 sq cm or 1% body area for infants and children, or less	15	19	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	71	284	$59
15274	Skin substitute graft to wound 100.0 sq cm or more of trunk, arms, or legs, each additional 100.0 sq cm or 1% body area for infants and children, or less	13	26	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	47	$125
Cefadroxil	Cefadroxil	19	121	$123

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$1,249	Integra LifeSciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for A. Peter Salas, MD, FACS, FACM?

Tedicare shows public-source Medicare data for A. Peter Salas, MD, FACS, FACM (NPI 1124189030), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does A. Peter Salas, MD, FACS, FACM have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to A. Peter Salas, MD, FACS, FACM?

A. Peter Salas, MD, FACS, FACM is linked to SURG-ELITE PC (billing NPI 1780878348) in the available physician profile data.

Does A. Peter Salas, MD, FACS, FACM have Open Payments data?

A. Peter Salas, MD, FACS, FACM has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.